INOVIO to Participate in Upcoming Investor Conferences in New York
News related to:INOVIO Pharmaceuticals, Inc · 1 min read
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /CourierPR/ -- INOVIO, a biotechnology company dedicated to developing and commercializing DNA medicines to combat HPV-related diseases, cancer, and infectious diseases, will participate in two upcoming investor conferences in New York.
At the Cantor Global Healthcare Conference, scheduled for September 9, INOVIO will host a fireside chat at 3:20 PM Eastern Time. The event will be webcast live, and a link to the stream is available: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=99315971&checkCompany=1&checkEmail=1&checkName=1
Additionally, INOVIO will present at the H.C. Wainwright 28th Annual Global Investment Conference, which will take place from September 11. The presentation will be available beginning at 7:00 AM ET, and the format will be virtual. The conference link is: https://journey.ct.events/view/eb47953c-3213-432d-92ca-13beb55c97ae
Replays of both presentations will be accessible for 90 days at the provided links. During these conferences, members of INOVIO’s management team will also host one-on-one meetings with investors.
The participation in these conferences is aimed at providing investors with an opportunity to gain insights into INOVIO’s latest advancements and strategies.